Cellectar Biosciences, Inc. (CLRB) Operating income 2016–2025
Cellectar Biosciences, Inc. (CLRB) annual operating income history from SEC filings — each fiscal year as reported.
-$23.0MFY2025 · since FY2016: -$9.4M → -$23.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.0M | +55.6% |
| FY2024 | -$51.8M | -32.9% |
| FY2023 | -$39.0M | -35.2% |
| FY2022 | -$28.8M | -19.4% |
| FY2021 | -$24.1M | -57.8% |
| FY2020 | -$15.3M | -7.8% |
| FY2019 | -$14.2M | -6.4% |
| FY2018 | -$13.3M | +2.0% |
| FY2017 | -$13.6M | -43.9% |
| FY2016 | -$9.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice